11 – 20 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Plasma protein profiling in a stage defined pancreatic cancer cohort – Implications for early diagnosis
(
- Contribution to journal › Article
-
Mark
Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma : a Nordic Lymphoma Group study
(
- Contribution to journal › Article
-
Mark
Technical advances of the recombinant antibody microarray technology platform for clinical immunoproteomics
(
- Contribution to journal › Article
- 2015
-
Mark
Advanced technologies and diagnostic spin-outs: an interview with Carl Borrebaeck.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma.
(
- Contribution to journal › Article
-
Mark
Combination of novel HER2-targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2-positive gastric cancer.
(
- Contribution to journal › Article
- 2014
-
Mark
Molecular design of recombinant scFv antibodies for site-specific photocoupling to β-cyclodextrin in solution and onto solid support.
(
- Contribution to journal › Article
-
Mark
Generation of miniaturized planar ecombinant antibody arrays using a microcantilever-based printer.
(
- Contribution to journal › Article
-
Mark
Antibody array generation and use.
(
- Contribution to journal › Article
- 2013
-
Mark
Nuclear T-STAR Protein Expression Correlates with HER2 Status, Hormone Receptor Negativity and Prolonged Recurrence Free Survival in Primary Breast Cancer and Decreased Cancer Cell Growth In Vitro.
(
- Contribution to journal › Article